Effect of sitagliptin, a dipeptidyl peptidase‐4 inhibitor, on beta‐cell function in patients with type 2 diabetes: a model‐based approach
Year: 2008
Type: article
Source: Diabetes Obesity and Metabolism
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Amylin Pharmaceuticals, Novartis
OpenAlex ID: W1968236091
